| | 1300031-49-5 Basic information More.. |
| Product Name: | I-BET151 (GSK1210151A) | | Synonyms: | 7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-2H-imidazo[4,5-c]quinolin-2-one;I-BET 151/GSK 1210151A;GSK1210151A (I-BET151);7-(3,5-diMethylisoxazol-4-yl)-8-Methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-iMidazo[4,5-c]quinolin-2(3H)-one;7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2;GSK 1210151A;I-BET 151;7-(3,5-Dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-2H-imidazo[4,5-c]quinolin-2-one I-BET151(GSK1210151A) | | CAS: | 1300031-49-5 | | MF: | C23H21N5O3 | | MW: | 415.44 | | EINECS: | | | Mol File: | 1300031-49-5.mol |  |
Use
I-BET151 (GSK1210151A) is a novel selective BET inhibitor for BRD2, BRD3 and BRD4 with IC50 of 0.5 M, 0.25 M, and 0.79 M in cell-free assays, respectively.
- I-BET151
-
- US $41.00-97.00 / mg
- 2025-11-02
- CAS:1300031-49-5
- Min. Order:
- Purity: 99.03%
- Supply Ability: 10g
- I-BET151 (GSK1210151A)
-
- US $1.00 / g
- 2020-01-13
- CAS:1300031-49-5
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 200kg
|
|
1300031-49-5
Recommend Suppliers |
|